Abstract:

【Abstract】Objective  To evaluate the relationship of the serum bilirubin levels and clinical adverse events in patients with acute myocardial infarction (AMI). Methods  Clinical data including age, body mass index, blood pressure, blood lipids and left ventricular ejection fraction (LVEF) of 109 patients with AMI and 100 control subjects were collected and compared. AMI patients were divided into adverse event group (n=48) and non- adverse event group (n=61). The serum total bilirubin (TBIL), direct bilirubin (DBIL) and indirect bilirubin (IBIL) were detected and compared by collecting 5 mL fasting venous blood. Results  Compared with the control group, values of body mass index, age, gender，blood pressure，blood lipids， fasting blood sugar and other clinical data showed no significant difference in AMI group (P > 0.05). The serum levels of TBIL and DBIL were significantly lower in AMI group than those of control group (P < 0.01). The total serum bilirubin and indirect bilirubin levels were significantly lower in clinical adverse event group compared with those of non-event group (P < 0.05). Conclusion  Changes in serum bilirubin levels have a certain relationship with the clinical adverse events in patients with acute myocardial infarction.

Key words: Serum Bilirubin, Acute Myocardial Infarction, Clinical Adverse Events